Cancer News and Research

Latest Cancer News and Research

Startup receives federal grant for developing technology to detect and treat stress, anxiety

A high-tech startup that uses game-based interventions to help users identify stress- and anxiety-related events in real time and receive a personalized intervention has been awarded a federal grant to partially develop its technology through research at Purdue University's College of Engineering.

28 Oct 2022

CHG may be the most effective irrigation solution for use during surgical treatment of bone tumors

The widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, suggests an experimental study in The Journal of Bone & Joint Surgery.

28 Oct 2022

Standard cutoff point for low testosterone levels may not be accurate for young men

The standard cutoff point for low testosterone levels may not be accurate for men in their mid-forties and younger, reports a study in The Journal of Urology, an Official Journal of the American Urological Association (AUA).

28 Oct 2022

UK Markey Cancer Center earns the rigorous NAPRC accreditation

The University of Kentucky Markey Cancer Center has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer.

28 Oct 2022

Cleveland Clinic awarded $12 million NIH grant to define how cytokines regulate inflammation

Cleveland Clinic's Lerner Research Institute was awarded a five-year $12 million grant by the National Cancer Institute, part of the National Institutes of Health, to define how cytokines - proteins produced during immune response - regulate inflammation and interact with cells and molecules surrounding tumors.

28 Oct 2022

Researchers propose origin-of-life molecule as therapeutic target for tailored cancer therapies

RNA, the molecule that gave rise to life, has been shown to be essential for repairing human genetic material and preventing mutations that might lead to developing cancer.

28 Oct 2022

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse models of multiple cancers.

28 Oct 2022

Specific stem cell protein found to be involved in the recurrence of medulloblastoma

The malignant brain tumor type medulloblastoma can become resistant to therapy which can cause relapse. Researchers at Uppsala University have discovered a certain protein that makes tumor cells resting and insensitive to radiation treatment.

28 Oct 2022

Cancer cells' sticky fingers contribute to building a barrier surrounding breast tumors

Researchers at Turku University and Åbo Akademi University, Finland, have identified that finger-like cellular extensions called filopodia contribute to building a barrier surrounding breast tumors.

28 Oct 2022

Brain Canada Foundation funds future leaders in Canadian brain research

Twenty early-career researchers from across Canada will receive $100,000 each in funding for innovative projects to better understand the brain, through one of Brain Canada's flagship programs Future Leaders in Canadian Brain Research.

28 Oct 2022

What are the contemporary hazards of cigarette smoking and benefits of quitting smoking by race, ethnicity, and sex among US adults?

Researchers quantified the association between cigarette smoking and all-cause and cause-specific deaths by sex, ethnicity, and race.

28 Oct 2022

Overall cancer death rates continue to decline in the United States, says Annual Report to the Nation

Overall cancer death rates continued to decline among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer. From 2014 to 2018, overall cancer incidence, or new cases of cancer, remained stable for men and children but increased for women and adolescents and young adults.

28 Oct 2022

Research reveals a differential clinical response to pembrolizumab in uterine cancer patients

New research from Yale Cancer Center reveals for the first time ever a differential clinical response to pembrolizumab in Lynch-like (mutated) vs methylated microsatellite instability-high (MSI-H) uterine cancer patients, increasing our understanding about the proportion of patients that derive benefit from immune checkpoint blockade.

28 Oct 2022

New breakthrough in understanding how deletion of certain genes can lead to cancer growth

Genetic mutations kick start cancers. Some mutations shuffle the genetic code, others come from the deletion of key genes.

28 Oct 2022

Commensal gut microbes from IBD patients produce genotoxic metabolites

Functional screening of human gut microbiota reveals a family of small molecule genotoxins called indolimines in patients with inflammatory bowel disease (IBD), according to a new study.

27 Oct 2022

Researchers use CRISPR-edited T cells to treat seriously ill children with resistant leukaemia

Researchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOS ICH) have used CRISPR/Cas9 technology to engineer donor T cells to try to treat seriously ill children with resistant leukaemia, who had otherwise exhausted all available therapies.

27 Oct 2022

Newly developed chemical compounds show promise as potential anticancer therapy

A University of Kentucky Markey Cancer Center researcher's team developed new chemical compounds that show promise as a potential anticancer therapy to treat aggressive tumors.

27 Oct 2022

An unprecedented list of health-threatening fungi released by the WHO

The WHO fungal priority pathogens list ranks pathogens that pose a serious risk of morbidity and mortality in humans.

27 Oct 2022

Study sheds light on why some patients respond better than others to immunotherapy

Immunotherapy, a biotherapy that boosts the ability of the immune system to recognize and attack mutant tumor cells, has transformed the treatment landscape for patients battling cancer, which emerges from the progressive accumulation of DNA mutations.

27 Oct 2022

Immune checkpoint therapy may be beneficial in certain cases of severe COVID-19

An article published in Science Advances suggests that a type of cancer treatment known as immune checkpoint blockade may be beneficial in certain cases of severe COVID-19.

27 Oct 2022

Cancer News and Research

Latest Cancer News and Research

Startup receives federal grant for developing technology to detect and treat stress, anxiety

CHG may be the most effective irrigation solution for use during surgical treatment of bone tumors

Standard cutoff point for low testosterone levels may not be accurate for young men

UK Markey Cancer Center earns the rigorous NAPRC accreditation

Cleveland Clinic awarded $12 million NIH grant to define how cytokines regulate inflammation

Researchers propose origin-of-life molecule as therapeutic target for tailored cancer therapies

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

Specific stem cell protein found to be involved in the recurrence of medulloblastoma

Cancer cells' sticky fingers contribute to building a barrier surrounding breast tumors

Brain Canada Foundation funds future leaders in Canadian brain research

What are the contemporary hazards of cigarette smoking and benefits of quitting smoking by race, ethnicity, and sex among US adults?

Overall cancer death rates continue to decline in the United States, says Annual Report to the Nation

Research reveals a differential clinical response to pembrolizumab in uterine cancer patients

New breakthrough in understanding how deletion of certain genes can lead to cancer growth

Commensal gut microbes from IBD patients produce genotoxic metabolites

Researchers use CRISPR-edited T cells to treat seriously ill children with resistant leukaemia

Newly developed chemical compounds show promise as potential anticancer therapy

An unprecedented list of health-threatening fungi released by the WHO

Study sheds light on why some patients respond better than others to immunotherapy

Immune checkpoint therapy may be beneficial in certain cases of severe COVID-19

Understanding the DNA Damage Response in Innate Immunity eBook

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

Newsletters you may be interested in